1. Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions
   Tomas Koltai et al, 2022, Journal of Evidence-Based Integrative Medicine CrossRef
2. Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy
   Julieta Afonso et al, 2023, Cancers CrossRef
3. New Insights Toward Nanostructured Drug Delivery of Plant-Derived Polyphenol Compounds: Cancer Treatment and Gene Expression Profiles
   Keyvan Khazei et al, 2021, Current Cancer Drug Targets CrossRef
4. Current Development and Application of Anaerobic Glycolytic Enzymes in Urothelial Cancer
   Yi-Fang Yang et al, 2021, International Journal of Molecular Sciences CrossRef
5. Silibinin Prevents TGFβ-Induced EMT of RPE in Proliferative Vitreoretinopathy by Inhibiting Stat3 and Smad3 Phosphorylation
   Xinqi Ma et al, 2023, Investigative Opthalmology & Visual Science CrossRef
6. Natural Phytochemicals in Bladder Cancer Prevention and Therapy
   Yong Xia et al, 2021, Frontiers in Oncology CrossRef
7. Oxidative stress in bladder cancer: an ally or an enemy?
   Fernando Mendes et al, 2021, Molecular Biology Reports CrossRef
8. Competitive glucose metabolism as a target to boost bladder cancer immunotherapy
   Julieta Afonso et al, 2020, Nature Reviews Urology CrossRef
9. De-methylation of miR-148a by arsenic trioxide enhances sensitivity to chemotherapy via inhibiting the NF-κB pathway and CSC like properties
   Yuting Wang et al, 2020, Experimental Cell Research CrossRef
10. Anti-cancer Effects of Silibinin: The Current Status in Cancer Chemoprevention
    Dominique Reed et al, 2020, Natural Products for Cancer Chemoprevention CrossRef